Skip to main content

Table 1 Clinicopathological characteristics of the testicular germ cell tumor cohort

From: m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance

Clinicopathological features TGCT patients (n = 122)
Median age, years (IQR) 28 (24–36)
Histological type
 Seminoma 56/122 (45.9%)
 Embryonal carcinoma 5/122 (4.1%)
 Postpubertal-type yolk sac tumor 0/122 (0%)
 Choriocarcinoma 0/122 (0%)
 Postpubertal-type teratoma 3/122 (2.5%)
 Mixed tumor 58/122 (47.5%)
Pathological stage
 I 78/122 (63.9%)
 II 23/122 (18.9%)
 III 21/122 (17.2%)
IGCCCG grouping (for metastatic disease)
 Good 31/44 (70.5%)
 Intermediate 6/44 (13.6%)
 Poor 7/44 (15.9%)
Clinicopathological features Primary TGCT tumor samples (n = 197)
Histological type
 Seminoma 75/197 (38.0%)
 Embryonal Carcinoma 39/197 (19.8%)
 Postpubertal-type yolk sac tumor 35/197 (17.8%)
 Choriocarcinoma 12/197 (6.1%)
 Postpubertal-type teratoma 36/197 (18.3%)
Clinicopathological features Metastatic TGCT tumor samples (n = 19)
Histological type
 Seminoma 1/19 (5.3%)
 Embryonal carcinoma 5/19 (26.3%)
 Postpubertal-type yolk sac tumor 3/19 (15.8%)
 Choriocarcinoma 1/19 (5.3%)
 Postpubertal-type teratoma 9/19 (47.3%)
Type of metastasis
 Lymph node 12/19 (63.2%)
 Visceral 7/19 (36.8%)
  1. IGCCCG International Germ Cell Cancer Collaborative Group, IQR interquartile range, TGCT testicular germ cell tumors